Bone health in cancer: ESMO Clinical Practice Guidelines

被引:289
|
作者
Coleman, R. [1 ]
Hadji, P. [2 ,3 ]
Body, J-J [4 ]
Santini, D. [5 ]
Chow, E. [6 ]
Terpos, E. [7 ]
Oudard, S. [8 ]
Bruland, O. [9 ,10 ]
Flamen, P. [11 ]
Kurth, A. [12 ,13 ]
Van Poznak, C. [14 ]
Aapro, M. [15 ]
Jordan, K. [16 ]
机构
[1] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England
[2] Frankfurt Ctr Bone Hlth, Frankfurt, Germany
[3] Philipps Univ Marburg, Marburg, Germany
[4] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[5] Univ Campus Biomed, Med Oncol Dept, Rome, Italy
[6] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[7] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[8] Paris Descartes Univ, Georges Pompidou Hosp, Dept Med Oncol, Paris, France
[9] Univ Oslo, Inst Clin Med, Oslo, Norway
[10] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway
[11] Univ Libre Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium
[12] Community Clin Middle Rhine, Dept Orthopaed & Trauma Surg, Campus Kemperhof, Koblenz, Germany
[13] Univ Med Mainz, Major Teaching Hosp, Mainz, Germany
[14] Univ Michigan, Ann Arbor, MI 48109 USA
[15] Genolier Canc Ctr, Genolier, Switzerland
[16] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
关键词
bone metastases; cancer treatment-induced bone loss; bone-targeted agents; Clinical Practice Guidelines; diagnosis; treatment; follow-up; EARLY BREAST-CANCER; ZOLEDRONIC ACID; MULTIPLE-MYELOMA; DOUBLE-BLIND; SOLID TUMORS; OPEN-LABEL; DENOSUMAB; METASTASES; PHASE-3; SURVIVAL;
D O I
10.1016/j.annonc.2020.07.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1650 / 1663
页数:14
相关论文
共 50 条
  • [1] Bone health in cancer patients: ESMO Clinical Practice Guidelines
    Coleman, R.
    Body, J. J.
    Aapro, M.
    Hadji, P.
    Herrstedt, J.
    ANNALS OF ONCOLOGY, 2014, 25 : 124 - 137
  • [2] Management of cancer pain: ESMO Clinical Practice Guidelines
    Ripamonti, C. I.
    Bandieri, E.
    Roila, F.
    ANNALS OF ONCOLOGY, 2011, 22 : vi69 - vi77
  • [3] Management of cancer pain: ESMO Clinical Practice Guidelines
    Ripamonti, C. I.
    Santini, D.
    Maranzano, E.
    Berti, M.
    Roila, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 139 - 154
  • [4] BRCA in breast cancer: ESMO Clinical Practice Guidelines
    Balmana, J.
    Diez, O.
    Rubio, I.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2010, 21 : v20 - v22
  • [5] Management of cancer pain: ESMO Clinical Practice Guidelines
    Jost, L.
    Roila, F.
    ANNALS OF ONCOLOGY, 2010, 21 : v257 - v260
  • [6] BRCA in breast cancer: ESMO Clinical Practice Guidelines
    Balmana, J.
    Diez, O.
    Rubio, I. T.
    Cardoso, F.
    ANNALS OF ONCOLOGY, 2011, 22 : vi31 - vi34
  • [7] Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines
    Bossi, P.
    Antonuzzo, A.
    Cherny, N. I.
    Rosengarten, O.
    Pernot, S.
    Trippa, F.
    Schuler, U.
    Snegovoy, A.
    Jordan, K.
    Ripamonti, C. I.
    ANNALS OF ONCOLOGY, 2018, 29 : 126 - 142
  • [8] Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
    Van Cutsem, E.
    Nordlinger, B.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2010, 21 : v93 - v97
  • [9] Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines†
    Hui, David
    Maddocks, Matthew
    Johnson, Miriam J.
    Ekstrom, Magnus
    Simon, Steffen T.
    Ogliari, Anna C.
    Booth, Sara
    Ripamonti, Carla, I
    ESMO OPEN, 2020, 5 (06)
  • [10] Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines
    Arends, J.
    Strasser, F.
    Gonella, S.
    Solheim, T. S.
    Madeddu, C.
    Ravasco, P.
    Buonaccorso, L.
    de van der Schueren, M. A. E.
    Baldwin, C.
    Chasen, M.
    Ripamonti, C., I
    ESMO OPEN, 2021, 6 (03)